The Timing of Cancer Drug Approvals in the United States and Europe

JAMA Netw Open. 2022 Jun 1;5(6):e2216191. doi: 10.1001/jamanetworkopen.2022.16191.
No abstract available

Publication types

  • Comment

MeSH terms

  • Drug Approval*
  • Europe
  • Humans
  • Neoplasms* / drug therapy
  • United States
  • United States Food and Drug Administration